"Sanders Takes on Big Pharma: Medicare Negotiates Drug Price Disparity and CEO Hearing Looms"

Senator Bernie Sanders issued a report highlighting the vast price differences of three drugs in the US compared to other countries, ahead of a hearing with the CEOs of the drugmakers. Medicare has begun negotiations with drugmakers over the cost of 10 expensive medications, including Eliquis and Stelara, despite the prices charged in other countries not being a factor in the negotiation process. The report also cited the profits and executive compensation of the pharmaceutical companies, while drug companies have expressed concerns that Medicare's price negotiations could impact research and development.